Dr. Martens Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Ije Nwokorie

Chief executive officer

UK£57.0k

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure3.1yrs
Board average tenure4yrs

Recent management updates

Recent updates


CEO

Ije Nwokorie (54 yo)

no data

Tenure

UK£57,000

Compensation

Mr. Onyeije Ogueri Nwokorie, also known as Ije, is Chief Brand Officer at Dr. Martens plc since February 01, 2024. He is Independent Non-Executive Director at Dr. Martens Limited and was Independent Non-Ex...


Leadership Team

NamePositionTenureCompensationOwnership
Onyeije Nwokorie
CEO & Chief Brand Officerno dataUK£57.00kno data
Kenneth Wilson
Executive Officerno dataUK£788.00k1.2%
€ 9.9m
Giles Wilson
CFO & Directorless than a yearno data0.017%
€ 139.3k
Geert Peeters
Chief Operating Officer6.6yrsno datano data
Graham Calder
Chief Technology Officerno datano datano data
Bridget Jolliffe
Chief People Officerno datano datano data
Emily Reichwald
Chief Sustainability Officerno datano datano data
Sean O'Neill
Chief Digital Officer6.8yrsno datano data
Derek Chan
President of APAC5.3yrsno datano data
Adam Meek
Chief Product Officer3.1yrsno datano data
Jennifer Somer
President of Americas3.2yrsno datano data
Mike Stopforth
President of EMEA1.7yrsno datano data

3.1yrs

Average Tenure

54yo

Average Age

Experienced Management: 3U2's management team is considered experienced (3.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Giles Wilson
CFO & Directorless than a yearno data0.017%
€ 139.3k
Andrew Harrison
Independent Non-Executive Director1.7yrsUK£62.00k0.0079%
€ 66.0k
Ian Rogers
Independent Non-Executive Director4yrsUK£68.00k0.0021%
€ 17.5k
Robyn Perriss
Independent Non-Executive Director4yrsUK£96.00k0.010%
€ 85.6k
Tara Alhadeff
Representative Non-Independent Non-Executive Director4yrsno datano data
Lynne Weedall
Senior Independent Non-Executive Director4yrsUK£101.00k0.0048%
€ 39.7k
Paul Mason
Chair of the Board9.3yrsUK£342.00k0.82%
€ 6.8m

4.0yrs

Average Tenure

53yo

Average Age

Experienced Board: 3U2's board of directors are considered experienced (4 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/27 05:12
End of Day Share Price 2025/01/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dr. Martens plc is covered by 12 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Richard TaylorBarclays
David RouxBofA Global Research
Louise SinglehurstGoldman Sachs